Skip to Content

2 Results Found

  • Article
  • Open Access
21 Citations
7,245 Views
16 Pages

Identification of Novel FNIN2 and FNIN3 Fibronectin-Derived Peptides That Promote Cell Adhesion, Proliferation and Differentiation in Primary Cells and Stem Cells

  • Eun-Ju Lee,
  • Khurshid Ahmad,
  • Shiva Pathak,
  • SunJu Lee and ,
  • Mohammad Hassan Baig,
  • Jee-Heon Jeong,
  • Kyung-Oh Doh,
  • Dong-Mok Lee and
  • Inho Choi
  • + 4 authors+ 0 author

In recent years, a major rise in the demand for biotherapeutic drugs has centered on enhancing the quality and efficacy of cell culture and developing new cell culture techniques. Here, we report fibronectin (FN) derived, novel peptides fibronectin-b...

(This article belongs to the Special Issue New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells)
  • Article
  • Open Access
1 Citations
3,442 Views
16 Pages

Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study

  • Jiyoung Keum,
  • Hee Seung Lee,
  • Jung Hyun Jo,
  • Moon Jae Chung and ,
  • Jeong Youp Park,
  • Seung Woo Park,
  • Si Young Song and
  • Seungmin Bang
  • + 3 authors+ 0 author

28 February 2022

FOLFIRINOX (oxaliplatin, leucovorin, irinotecan, and 5-fluorouracil) is a first-line chemotherapy for metastatic pancreatic cancer (PC). Chemotherapy-induced neutropenia is one of the most serious adverse events associated with advanced PC. Although...

(This article belongs to the Special Issue Pancreatic Cancer Treatment: Surgery, Chemotherapy, Chemoradiation, and Upcoming Trends)